Startup | November 18, 2021
Illumina and Sequoia Capital China selects startups for Genomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
The company has operations in North America, Asia, and Europe,
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Biocon Biologics and Viatris co-developed the products
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Subscribe To Our Newsletter & Stay Updated
